dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Malinverni, R. |
dc.contributor.author | Bargay, J. |
dc.contributor.author | Marcé, Silvia |
dc.contributor.author | Garrido, A. |
dc.contributor.author | Valcarcel Ferreiras, David |
dc.contributor.author | Cabezón, Marta |
dc.contributor.author | Xicoy, Blanca |
dc.date.accessioned | 2021-05-27T07:54:57Z |
dc.date.available | 2021-05-27T07:54:57Z |
dc.date.issued | 2021-01-14 |
dc.identifier.citation | Cabezón M, Malinverni R, Bargay J, Xicoy B, Marcé S, Garrido A, et al. Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival. Clin Epigenetics. 2021 Jan 14;13:9. |
dc.identifier.issn | 1868-7083 |
dc.identifier.uri | https://hdl.handle.net/11351/5979 |
dc.description | Metilación del ADN; Síndromes mielodisplásicos; Factores pronósticos |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Clinical Epigenetics;13 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Leucèmia mieloide aguda |
dc.subject | Prognosi |
dc.subject | Metilació |
dc.subject.mesh | Leukemia, Myeloid, Acute |
dc.subject.mesh | DNA Methylation |
dc.subject.mesh | Diagnosis |
dc.title | Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s13148-021-01002-y |
dc.subject.decs | leucemia mielomonocítica aguda |
dc.subject.decs | metilación del ADN |
dc.subject.decs | diagnóstico |
dc.relation.publishversion | https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-021-01002-y |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Cabezón M, Xicoy B] Hematology Laboratory Service, ICO Badalona Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain. [Malinverni R] Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute (IJC), Campus ICO GTP UAB, Badalona, Spain. [Bargay J] Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain. [Marcé S] Hematology Laboratory Service, ICO Badalona Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. [Garrido A] Hematology Service, Hospital de Sant Pau, Barcelona, Spain. [Valcárcel D] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33446256 |
dc.identifier.wos | 000609189700001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/1PN/2008-2011/PI11%2F02519 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-094005-B-I00 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PIE16%2F00011 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR305 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |